Elevance Health reaffirms FY 2023 GAAP EPS >$29.09 and adjusted EPS >$32.85

Elevance Health, Inc.

Officers reaffirm full-year 2023 GAAP net income >$29.09 per share, including ~$3.76 unfavorable items.
Adjusted net income guidance unchanged at >$32.85 per share, excluding the unfavorable items.
Reaffirmation made during investor meetings over the next ten days; no new adjustments beyond Q2 2023.
Guidance does not reflect any additional items other than those reported in Q2 2023 earnings release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.